Sprint Bioscience AB operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sprint Bioscience AB with three other
companies in this sector in Sweden:
Curando Nordic AB
sales of 15.64 million Swedish Kronor [US$1.61 million]
Xbrane Biopharma Ab
(20.49 million Swedish Kronor [US$2.11 million]
of which 380%
was Biosimilars), and
Active Biotech AB
(20.05 million Swedish Kronor [US$2.07 million]
of which 80%
was Rental revenues).